These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

898 related items for PubMed ID: 19235659

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Timing of hepatitis C antiviral therapy in patients with advanced liver disease: a decision analysis model.
    Saab S, Hunt DR, Stone MA, McClune A, Tong MJ.
    Liver Transpl; 2010 Jun; 16(6):748-59. PubMed ID: 20517909
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
    Rayhill SC, Wu YM, Katz DA, Voigt MD, Labrecque DR, Kirby PA, Mitros FA, Kalil RS, Miller RA, Stolpen AH, Schmidt WN.
    Transplantation; 2007 Aug 15; 84(3):331-9. PubMed ID: 17700157
    [Abstract] [Full Text] [Related]

  • 5. Advances in the treatment of hepatitis C.
    Lawrence SP.
    Adv Intern Med; 2000 Aug 15; 45():65-105. PubMed ID: 10635046
    [Abstract] [Full Text] [Related]

  • 6. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.
    Gallegos-Orozco JF, Yosephy A, Noble B, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan D, Moss A, de Petris G, Williams JW, Rakela J, Vargas HE.
    Liver Transpl; 2009 Dec 15; 15(12):1872-81. PubMed ID: 19938138
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fibrosis progression and the pros and cons of antiviral therapy for hepatitis C virus recurrence after liver transplantation: a review.
    De Martin E, Senzolo M, Gambato M, Germani G, Vitale A, Russo FR, Burra P.
    Transplant Proc; 2010 Dec 15; 42(6):2223-5. PubMed ID: 20692449
    [Abstract] [Full Text] [Related]

  • 9. Liver transplantation for HCV-associated liver cirrhosis: predictors of outcomes in a population with significant genotype 3 and 4 distribution.
    Zekry A, Whiting P, Crawford DH, Angus PW, Jeffrey GP, Padbury RT, Gane EJ, McCaughan GW, Australian and New Zealand Liver Transplant Clinical Study Group.
    Liver Transpl; 2003 Apr 15; 9(4):339-47. PubMed ID: 12682883
    [Abstract] [Full Text] [Related]

  • 10. Chronic hepatitis C and liver transplantation.
    Davis GL.
    Rev Gastroenterol Disord; 2004 Apr 15; 4(1):7-17. PubMed ID: 15029106
    [Abstract] [Full Text] [Related]

  • 11. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.
    Manousou P, Samonakis D, Cholongitas E, Patch D, O'Beirne J, Dhillon AP, Rolles K, McCormick A, Hayes P, Burroughs AK.
    Liver Transpl; 2009 Dec 15; 15(12):1783-91. PubMed ID: 19938143
    [Abstract] [Full Text] [Related]

  • 12. Liver transplantation and hepatitis C.
    Willems M, Metselaar HJ, Tilanus HW, Schalm SW, de Man RA.
    Transpl Int; 2002 Mar 15; 15(2-3):61-72. PubMed ID: 11935162
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of recurrent HCV infection after liver transplantation].
    Ostojić R.
    Acta Med Croatica; 2005 Mar 15; 59(5):443-6. PubMed ID: 16381241
    [Abstract] [Full Text] [Related]

  • 14. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J.
    Transplant Proc; 2009 Apr 15; 41(3):1041-3. PubMed ID: 19376421
    [Abstract] [Full Text] [Related]

  • 15. The natural history of recurrent hepatitis C and what influences this.
    Gane EJ.
    Liver Transpl; 2008 Oct 15; 14 Suppl 2():S36-44. PubMed ID: 18825724
    [Abstract] [Full Text] [Related]

  • 16. Outcomes of acute rejection after interferon therapy in liver transplant recipients.
    Saab S, Kalmaz D, Gajjar NA, Hiatt J, Durazo F, Han S, Farmer DG, Ghobrial RM, Yersiz H, Goldstein LI, Lassman CR, Busuttil RW.
    Liver Transpl; 2004 Jul 15; 10(7):859-67. PubMed ID: 15237369
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic management of recurrent hepatitis C after liver transplantation.
    Teixeira R, Menezes EG, Schiano TD.
    Liver Int; 2007 Apr 15; 27(3):302-12. PubMed ID: 17355450
    [Abstract] [Full Text] [Related]

  • 18. Course and treatment of recurrent Hepatitis C after liver transplantation.
    Neumann UP, Neuhaus P.
    Minerva Gastroenterol Dietol; 2004 Mar 15; 50(1):61-6. PubMed ID: 15719007
    [Abstract] [Full Text] [Related]

  • 19. Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis.
    Berenguer M, Prieto M, Palau A, Rayón JM, Carrasco D, Juan FS, López-Labrador FX, Moreno R, Mir J, Berenguer J.
    Liver Transpl; 2003 Mar 15; 9(3):228-35. PubMed ID: 12619018
    [Abstract] [Full Text] [Related]

  • 20. Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survival.
    Ghabril M, Dickson RC, Machicao VI, Aranda-Michel J, Keaveny A, Rosser B, Bonatti H, Krishna M, Yataco M, Satyanarayana R, Harnois D, Hewitt W, Willingham DD, Grewal H, Hughes CB, Nguyen J.
    Liver Transpl; 2007 Dec 15; 13(12):1717-27. PubMed ID: 18044750
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.